Breast cancers with high expressions of CSF-1R on carcinoma cells are associated with significantly poor breast cancer-specific survival compared to tumors with low expression (Figure 3A) (HR 1.63; 95% CI 1.26–2.09; p < 0.001). Here, CSF1R is linked to carcinoma.